{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.55 vs. cons $4.49",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$9.10B vs. cons $9.02B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Underlying sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.4% vs. cons 3.0%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$17.90 vs. cons $17.89 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$4.55 vs. cons $4.58 (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 beat can initially lift shares, but FY2026 guidance near ~$17.90 versus consensus $17.89 implies roughly $9.02 of H2 EPS after predicted H1 EPS of $8.88, below the prior consensus-implied H2 requirement of about $9.07; limited out-period revisions should cause most of the day-1 gain to fade.",
  "day5_confidence": "MEDIUM"
}